Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi

[1]  Alongkot Ponlawat,et al.  Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles , 2017, Malaria Journal.

[2]  Rowena Asugeni,et al.  Incidental mosquitocidal effect of an ivermectin mass drug administration on Anopheles farauti conducted for scabies control in the Solomon Islands , 2017, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  Ruben O. Conner,et al.  Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial , 2016, The Journal of infectious diseases.

[4]  Duolao Wang,et al.  Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya , 2016, JMIR research protocols.

[5]  Q. Bassat,et al.  Filling gaps on ivermectin knowledge: effects on the survival and reproduction of Anopheles aquasalis, a Latin American malaria vector , 2016, Malaria Journal.

[6]  Q. Bassat,et al.  Declining malaria transmission in rural Amazon: changing epidemiology and challenges to achieve elimination , 2016, Malaria Journal.

[7]  M. Grillet,et al.  Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus , 2016, Parasites & Vectors.

[8]  Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala. , 2016, Releve epidemiologique hebdomadaire.

[9]  Z. Bisoffi,et al.  Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador , 2015, PLoS neglected tropical diseases.

[10]  J. Lobo,et al.  Low doses of ivermectin cause sensory and locomotor disorders in dung beetles , 2015, Scientific Reports.

[11]  E. Cupp,et al.  Elimination of Onchocerciasis from Mexico , 2015, PLoS neglected tropical diseases.

[12]  Hannah C. Slater,et al.  Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda , 2015, Malaria Journal.

[13]  Y. Linton,et al.  Establishment of a free-mating, long-standing and highly productive laboratory colony of Anopheles darlingi from the Peruvian Amazon , 2015, Malaria Journal.

[14]  C. Snow,et al.  Characterization of the target of ivermectin, the glutamate-gated chloride channel, from Anopheles gambiae , 2015, The Journal of Experimental Biology.

[15]  A. Dondorp,et al.  Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance , 2015, Expert review of anti-infective therapy.

[16]  A. Lescano,et al.  Molecular Epidemiology of Plasmodium falciparum Malaria Outbreak, Tumbes, Peru, 2010–2012 , 2015, Emerging infectious diseases.

[17]  Teun Bousema,et al.  The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study. , 2014, The Journal of infectious diseases.

[18]  Kevin C. Kobylinski,et al.  Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments , 2014, Malaria Journal.

[19]  Kevin C. Kobylinski,et al.  Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control. , 2014, The American journal of tropical medicine and hygiene.

[20]  F. Gobbi,et al.  Prevalence of strongyloidiasis in Latin America: a systematic review of the literature , 2014, Epidemiology and Infection.

[21]  M. Cabada,et al.  Prevalence of soil-transmitted helminths after mass albendazole administration in an indigenous community of the Manu jungle in Peru , 2014, Pathogens and global health.

[22]  C. Mackenzie,et al.  Interruption of Infection Transmission in the Onchocerciasis Focus of Ecuador Leading to the Cessation of Ivermectin Distribution , 2014, PLoS neglected tropical diseases.

[23]  E. Ashley,et al.  Mass primaquine treatment to eliminate vivax malaria: lessons from the past , 2014, Malaria Journal.

[24]  F. Reichert,et al.  Hookworm-related cutaneous larva migrans in northern Brazil: resolution of clinical pathology after a single dose of ivermectin. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Q. Bassat,et al.  Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination , 2013, Malaria Journal.

[26]  Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification by WHO of elimination of transmission in Colombia. , 2013, Releve epidemiologique hebdomadaire.

[27]  Kevin C Kobylinski,et al.  Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae , 2012, Malaria Journal.

[28]  C. Álvarez,et al.  [The effect of ivermectin on geohelminth frequency (i.e. as used in the onchocerciasis control program in Colombia)]. , 2012, Revista de salud publica.

[29]  U. Hengge,et al.  Acute Morbidity Associated with Scabies and Other Ectoparasitoses Rapidly Improves After Treatment with Ivermectin , 2012, Pediatric dermatology.

[30]  F. Nosten,et al.  Randomized, Double-Blind, Placebo-Controlled Trial of Monthly versus Bimonthly Dihydroartemisinin-Piperaquine Chemoprevention in Adults at High Risk of Malaria , 2012, Antimicrobial Agents and Chemotherapy.

[31]  G. Shanks.  Control and elimination of Plasmodium vivax. , 2012, Advances in parasitology.

[32]  Kevin C. Kobylinski,et al.  Comparative evaluation of systemic drugs for their effects against Anopheles gambiae. , 2012, Acta tropica.

[33]  Hélène Hiwat,et al.  Ecology of Anopheles darlingi Root with respect to vector importance: a review , 2011, Parasites & Vectors.

[34]  E. Cupp,et al.  Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy. , 2011, Acta tropica.

[35]  L. Jaeger,et al.  Prevalence and epidemiology of intestinal parasitism, as revealed by three distinct techniques in an endemic area in the Brazilian Amazon , 2011, Annals of tropical medicine and parasitology.

[36]  Kevin C. Kobylinski,et al.  Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. , 2011, The American journal of tropical medicine and hygiene.

[37]  S. Meshnick,et al.  Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment , 2011, PloS one.

[38]  R. Price,et al.  Plasmodium vivax Recurrence Following Falciparum and Mixed Species Malaria: Risk Factors and Effect of Antimalarial Kinetics , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  P. Ribolla,et al.  Population dynamics, structure and behavior of Anopheles darlingi in a rural settlement in the Amazon rainforest of Acre, Brazil , 2011, Malaria Journal.

[40]  Kevin C. Kobylinski,et al.  Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors , 2010, Malaria Journal.

[41]  Massamba Sylla,et al.  The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. , 2010, Acta tropica.

[42]  Elizabeth Ashley,et al.  Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial , 2010, The Lancet. Infectious diseases.

[43]  Caroline W. Kabaria,et al.  The dominant Anopheles vectors of human malaria in the Americas: occurrence data, distribution maps and bionomic précis , 2010, Parasites & Vectors.

[44]  F. Ou,et al.  Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine , 2010, Malaria Journal.

[45]  R. Girod,et al.  Anopheles darlingi bionomics and transmission of Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae in Amerindian villages of the Upper-Maroni Amazonian forest, French Guiana. , 2008, Memorias do Instituto Oswaldo Cruz.

[46]  M. Rowland,et al.  A Randomised Trial of an Eight-Week, Once Weekly Primaquine Regimen to Prevent Relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan , 2008, PloS one.

[47]  Y. Rubio-Palis,et al.  Abundance, biting behaviour and parous rate of anopheline mosquito species in relation to malaria incidence in gold‐mining areas of southern Venezuela , 2007, Medical and veterinary entomology.

[48]  R. Crnjar,et al.  Effects of Avermectins on Olfactory Responses of Culicoides imicola (Diptera: Ceratopogonidae) , 2007, Journal of medical entomology.

[49]  S. Kietinun,et al.  Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[50]  E. Cupp,et al.  Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. , 2005, The American journal of tropical medicine and hygiene.

[51]  M. Muehlen,et al.  Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. , 2004, Bulletin of the World Health Organization.

[52]  O. Liesenfeld,et al.  Efficacy of Ivermectin in a Patient Population Concomitantly Infected with Intestinal Helminths and Ectoparasites , 2004, Arzneimittelforschung.

[53]  J. Heukelbach,et al.  Ectoparasites—the underestimated realm , 2004, The Lancet.

[54]  M. Tada,et al.  Seasonal Malaria Transmission and Variation of Anopheline Density in Two Distinct Endemic Areas in Brazilian Amazônia , 2003, Journal of medical entomology.

[55]  R. Carter.  Speculations on the origins of Plasmodium vivax malaria. , 2003, Trends in parasitology.

[56]  Akira Kaneko,et al.  Malaria eradication on islands , 2000, The Lancet.

[57]  M. Alpers,et al.  Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival , 1999, Medical and veterinary entomology.

[58]  G. Snounou,et al.  A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. , 1999, The American journal of tropical medicine and hygiene.

[59]  G. Weil,et al.  Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[60]  D. Addiss,et al.  Ultrasonographic assessment of the adulticidal efficacy of repeat high‐dose ivermectin in bancroftian filariasis , 1996, Tropical medicine & international health : TM & IH.

[61]  E. Cupp,et al.  Effects of three-month doses of ivermectin on adult Onchocerca volvulus. , 1992, The American journal of tropical medicine and hygiene.

[62]  S. Looareesuwan,et al.  HIGH RATE OF PLASMODIUM VIVAX RELAPSE FOLLOWING TREATMENT OF FALCIPARUM MALARIA IN THAILAND , 1987, The Lancet.

[63]  D. Mattingly,et al.  INTRACRANIAL HYPERTENSION AND STEROIDS. , 1964, Lancet.